ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model.

Carsten U Niemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.